StockData
Allarity Therapeutics, Inc. logo

Allarity Therapeutics, Inc. (ALLR) stock

ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.84−0.03 (-3.91%)

Close on Nov 17, 2026Market cap $13.38MP/E –Yield –

Allarity Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Allarity Therapeutics's total debt was $20.86M at Jun 30, 2026. For fiscal 2025 it was $0, down 100.0% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0-100.0%
FY2023Dec 31, 2023$250.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$20.86M–
Q1 FY2026Mar 31, 2026$20.08M–
Q4 FY2025Dec 31, 2025$0–
Q4 FY2023Dec 31, 2023$250.00K–

More Allarity Therapeutics figures

See a number that looks wrong?